{
    "title": "Roche, AbbVie leukemia drug superior to older medicine in study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5104053/Roche-AbbVie-leukemia-drug-superior-older-medicine-study.html",
    "date": "2017-11-21",
    "keywords": [
        "percent",
        "treanda",
        "cll",
        "venclexta",
        "study",
        "response",
        "pfs",
        "cancer",
        "bill",
        "berkrot",
        "leukemia",
        "combination",
        "roche",
        "approval",
        "confirmation",
        "phase",
        "iii",
        "society",
        "treatment",
        "versus",
        "group",
        "type",
        "drug",
        "disease",
        "rituxan",
        "stage",
        "abbvie",
        "mutation",
        "therapy",
        "trial",
        "contingent",
        "benefit",
        "month",
        "hematology",
        "ash",
        "meeting",
        "atlanta",
        "way",
        "time",
        "worsening",
        "survival",
        "bendamustine",
        "highrisk",
        "analysis",
        "relapsedrefractory",
        "improvement",
        "bendamustinerituxan",
        "summary",
        "rate",
        "meaning",
        "sign",
        "bone",
        "marrow",
        "assessment",
        "scan",
        "control",
        "blood",
        "year",
        "rituximab",
        "biogen",
        "reporting"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}